Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 285440
MIM: 608614
HGNC: 23198
Ensembl: ENSG00000145476
Variants:
dbSNP: 285440
ClinVar: 285440
TCGA: ENSG00000145476
COSMIC: CYP4V2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000145476 | ENST00000378802 | Q6ZWL3 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36675035 | 2023 | Structural Investigation of Beta-Cyclodextrin Complexes with Cannabidiol and Delta-9-Tetrahydrocannabinol in 1:1 and 2:1 Host-Guest Stoichiometry: Molecular Docking and Density Functional Calculations. | 2 |
| 36795063 | 2023 | An In-Depth Single-Gene Worldwide Carrier Frequency and Genetic Prevalence Analysis of CYP4V2 as the Cause of Bietti Crystalline Dystrophy. | 2 |
| 38066650 | 2023 | CYP4V2 rs56413992 C > T was associated with the risk of coronary heart disease in the Chinese Han population: a case-control study. | 0 |
| 36675035 | 2023 | Structural Investigation of Beta-Cyclodextrin Complexes with Cannabidiol and Delta-9-Tetrahydrocannabinol in 1:1 and 2:1 Host-Guest Stoichiometry: Molecular Docking and Density Functional Calculations. | 2 |
| 36795063 | 2023 | An In-Depth Single-Gene Worldwide Carrier Frequency and Genetic Prevalence Analysis of CYP4V2 as the Cause of Bietti Crystalline Dystrophy. | 2 |
| 38066650 | 2023 | CYP4V2 rs56413992 C > T was associated with the risk of coronary heart disease in the Chinese Han population: a case-control study. | 0 |
| 34798124 | 2022 | CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD). | 3 |
| 34923510 | 2022 | PREDICTED PROTEIN STRUCTURE VARIATIONS INDICATE THE CLINICAL PRESENTATION OF CYP4V2-RELATED BIETTI CRYSTALLINE DYSTROPHY. | 4 |
| 36437455 | 2022 | CYP4 subfamily V member 2 (CYP4V2) polymorphisms were associated with ischemic stroke in Chinese Han population. | 2 |
| 34798124 | 2022 | CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD). | 3 |
| 34923510 | 2022 | PREDICTED PROTEIN STRUCTURE VARIATIONS INDICATE THE CLINICAL PRESENTATION OF CYP4V2-RELATED BIETTI CRYSTALLINE DYSTROPHY. | 4 |
| 36437455 | 2022 | CYP4 subfamily V member 2 (CYP4V2) polymorphisms were associated with ischemic stroke in Chinese Han population. | 2 |
| 33636399 | 2021 | Genotype and Long-term Clinical Course of Bietti Crystalline Dystrophy in Korean and Japanese Patients. | 6 |
| 33964374 | 2021 | New compound heterozygous CYP4V2 mutations in bietti crystalline corneoretinal dystrophy. | 0 |
| 34310258 | 2021 | Crystals deposits in the anterior and posterior lens cortex in Bietti corneo-retinal dystrophy. | 1 |
Citation
Dessen P
CYP4V2 (cytochrome P450 family 4 subfamily V member 2)
Atlas Genet Cytogenet Oncol Haematol. 2014-11-01
Online version: http://atlasgeneticsoncology.org/gene/62267/cyp4v2-(cytochrome-p450-family-4-subfamily-v-member-2)
